Business
OneMedNet Announces Filing of Registration Statement on Form S-4 in Connection with its Proposed Business Combination with Data Knights Acquisition Corp.
Reflects continued advancement in the business combination process; transaction remains on schedule to be completed during the second half of 2022Includes
About this update from Onemednet Corp
[{"type":"text","content":"Reflects continued advancement in the business combination process; transaction remains on schedule to be completed during the second half of 2022Includes OneMedNet's latest quarterly results for the first quarter of 2022, reflecting continued strong business performanceMINNEAPOLIS, MN and LONDON, UK / ACCESSWIRE / July 22, 2022 / OneMedNet Corporation, the leading curator of regulatory-grade Imaging Real Word Data (\"iRWDTM\") and Data Knights Acquisition Corp. (\"Data Knights\") (Nasdaq: DKDCA, DKDCW), a publicly-traded special purpose acquisition company, today announced the filing of a registration statement on Form S-4 (the \"Registration Statement\"), with the U.S. Securities and Exchange Commission (SEC).The Registration Statement contains a preliminary proxy statement and prospectus, in connection with OneMedNet's previously announced proposed business combination with Data Knights. While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about OneMedNet and the proposed business combination with Data Knights.On April 25, 2022, Data Knights entered into a merger agreement with OneMedNet. The merger is expected be completed in the second half of 2022, subject to approval by Data Knights' shareholders, the Registration Statement being declared effective by the SEC, and other customary closing conditions and is expected to trade on the under the symbol \"ONMD.\" The transaction values OneMedNet at a pro forma enterprise value of $317 million.Included in the Registration Statement are OneMedNet's financial results for the first quarter of 2022. For the period, OneMedNet generated $233,966 of net sales, an increase of 34% compared to the first quarter of 2021. OneMedNet 's full financial results and related disclosures can be found in the Registration Statement, which we encourage you to read. Included in the Registration Statement are OneMedNet's financial results for the first quarter of 2022.OneMedNet provides innovative solutions regarding the clinical image archives of healthcare providers. It securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers and regulators. FDA uses RWD and RWE to monitor post-market safety and adverse eve...